Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes
Authors
Keywords
Copeptin, Vasopressin, Type 2 diabetes, Cardiovascular disease, Diabetic kidney disease, Epidemiology
Journal
Cardiovascular Diabetology
Volume 17, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-02
DOI
10.1186/s12933-018-0753-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease
- (2018) William F. Clark et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of hydration on plasma copeptin, glycemia and gluco-regulatory hormones: a water intervention in humans
- (2017) Sofia Enhörning et al. EUROPEAN JOURNAL OF NUTRITION
- Effect of increased water intake on plasma copeptin in healthy adults
- (2017) Guillaume Lemetais et al. EUROPEAN JOURNAL OF NUTRITION
- Antagonism of vasopressin V2 receptor improves albuminuria at the early stage of diabetic nephropathy in a mouse model of type 2 diabetes
- (2017) Ray El Boustany et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The vasopressin system: new insights for patients with kidney diseases
- (2017) W. F. Clark et al. JOURNAL OF INTERNAL MEDICINE
- Vasopressin and metabolic disorders: translation from experimental models to clinical use
- (2017) K. Nakamura et al. JOURNAL OF INTERNAL MEDICINE
- Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke
- (2017) Wen-Jun Tu et al. NEUROLOGY
- Increased Levels of Copeptin, a Surrogate Marker of Arginine Vasopressin, Are Associated with an Increased Risk of Chronic Kidney Disease in a General Population
- (2016) Irina Tasevska et al. AMERICAN JOURNAL OF NEPHROLOGY
- The influence of body composition on renal function in patients with coronary artery disease and its prognostic significance: a retrospective cohort study
- (2016) Yong Peng et al. Cardiovascular Diabetology
- Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People With Long-standing Type 1 Diabetes
- (2016) Gilberto Velho et al. DIABETES CARE
- Copeptin and the risk of incident stroke, CHD and cardiovascular mortality in older men with and without diabetes: The British Regional Heart Study
- (2016) S. Goya Wannamethee et al. DIABETOLOGIA
- Plasma Copeptin, AVP Gene Variants, and Incidence of Type 2 Diabetes in a Cohort From the Community
- (2016) Ronan Roussel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Copeptin is an independent predictor of diabetic heart disease and death
- (2015) Sofia Enhörning et al. AMERICAN HEART JOURNAL
- Plasma Copeptin and Decline in Renal Function in a Cohort from the Community: The Prospective D.E.S.I.R. Study
- (2015) Ronan Roussel et al. AMERICAN JOURNAL OF NEPHROLOGY
- Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats
- (2015) Christopher Taveau et al. DIABETOLOGIA
- Copeptin predicts coronary artery disease cardiovascular and total mortality
- (2015) Irina Tasevska et al. HEART
- Copeptin, Insulin Resistance, and Risk of Incident Diabetes in Older Men
- (2015) S. Goya Wannamethee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial
- (2015) Jessica M Sontrop et al. BMJ Open
- Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study
- (2014) Cornelia Then et al. ACTA DIABETOLOGICA
- Association of Serum Concentration of TNFR1 With All-Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow-up of the SURDIAGENE Cohort
- (2014) Pierre-Jean Saulnier et al. DIABETES CARE
- Comparison Between Copeptin and Vasopressin in a Population From the Community and in People With Chronic Kidney Disease
- (2014) Ronan Roussel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
- (2013) G. Velho et al. DIABETES CARE
- Copeptin, a surrogate marker for arginine vasopressin, is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)
- (2013) W. E. Boertien et al. DIABETOLOGIA
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Vasopressin: a novel target for the prevention and retardation of kidney disease?
- (2013) Lise Bankir et al. Nature Reviews Nephrology
- Prognostic Value of Resting Heart Rate on Cardiovascular and Renal Outcomes in Type 2 Diabetic Patients: A competing risk analysis in a prospective cohort
- (2012) A. Miot et al. DIABETES CARE
- Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
- (2012) A. Abbasi et al. DIABETOLOGIA
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
- (2012) et al. EUROPEAN HEART JOURNAL
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
- (2012) Vicente E. Torres et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vasopressin V1a and V1b Receptors: From Molecules to Physiological Systems
- (2012) Taka-aki Koshimizu et al. PHYSIOLOGICAL REVIEWS
- Notice
- (2012) Kidney International Supplements
- Copeptin Levels Associate with Cardiovascular Events in Patients with ESRD and Type 2 Diabetes Mellitus
- (2011) W. Fenske et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Plasma Copeptin and the Risk of Diabetes Mellitus
- (2010) Sofia Enhörning et al. CIRCULATION
- Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome
- (2009) Umer Saleem et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Copeptin, a surrogate marker of vasopressin, is associated with microalbuminuria in a large population cohort
- (2009) Esther Meijer et al. KIDNEY INTERNATIONAL
- Copeptin, a Surrogate Marker of Vasopressin, Is Associated With Accelerated Renal Function Decline in Renal Transplant Recipients
- (2009) Esther Meijer et al. TRANSPLANTATION
- Gender and renal function influence plasma levels of copeptin in healthy individuals
- (2008) Sanjay S. Bhandari et al. CLINICAL SCIENCE
- Copeptin in the Differential Diagnosis of Hyponatremia
- (2008) Wiebke Fenske et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started